Abstract

AbstractThe theme of this presentation is based on the premise that, despite the existence of differences in specific stability testing protocols between different types of products of the same manufacturer and between similar products of different manufacturers, it is possible to generalize somewhat and to identify elements common to any stability testing program. In terms of stability testing, a drug product may be viewed as passing through a series of distinct, identifiable stages in its development, which represents a progression of stability testing with product maturation. Within this progression, a range of testing protocols, methods and mathematical models may be utilized with each successive program designed to augment the data base of the product and thereby strengthen and expand the conclusions reached during each preceding phase. Differing types and amounts of information are sought at each stage which are important to the assignment of an expiration date, thus giving rise to widely differing ...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.